Physician profile
Steven J Stanton
NPI 1043214919
$4,706.99
in general payments reported to CMS, 2019-2025
35 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $373 · 2021: $1,865 · 2022: $623 · 2023: $755 · 2024: $402 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607 · Education: $39.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.93 |
| Education | $39.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,200.00 | 2021 | |
| Imbed Biosciences INC. | $533.90 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $359.64 | 2021-2025 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $316.54 | 2020-2025 | Jublia |
| Horizon Therapeutics Plc | $312.63 | 2019-2023 | Krystexxa |
| Organogenesis INC. | $228.33 | 2021-2024 | Nushield |
| Hikma Pharmaceuticals USA | $201.92 | 2019-2022 | |
| Smith+Nephew, INC. | $167.75 | 2019-2024 | Renasys Go V2 Home |
| Mayne Pharma Commercial LLC | $137.18 | 2022 | |
| Medtronic, INC. | $120.85 | 2023 | Hawkone |
| Bone Support INC. | $120.62 | 2025 | Ceramentbone Void Filler, Cerament G |
| Kerecis Limited | $119.00 | 2020-2022 | |
| Treace Medical Concepts, INC. | $112.40 | 2024 | |
| Stryker Corporation | $97.51 | 2020 | |
| Mimedx Group, INC. | $91.47 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $65.96 | 2019 | |
| Cook Medical LLC | $56.05 | 2024 | Zilver Ptx |
| Averitas Pharma INC. | $47.65 | 2023-2025 | Qutenza |
| Convatec INC. | $37.09 | 2023-2024 | |
| Bioventus LLC | $35.34 | 2021 | |
| Csl Behring | $34.73 | 2023 | Kcentra |
| Ani Pharmaceuticals, INC. | $32.70 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $29.32 | 2025 | Krystexxa |
| Anika Therapeutics, INC. | $28.80 | 2022 | |
| Medimetriks Pharmaceuticals, INC. | $23.67 | 2025 | Genadur, Neo-Synalar, Clindacin Etz |
| Merck Sharp & Dohme LLC | $23.49 | 2019 | |
| Amniox Medical, INC. | $22.65 | 2019 | |
| Innocoll Pharmaceuticals Limited | $22.33 | 2021 | |
| Paragon 28, INC. | $22.29 | 2023 | |
| Nevro Corp. | $21.38 | 2022 | |
| Mckesson Medical-Surgical, INC. | $20.00 | 2021 | |
| Advanced Oxygen Therapy INC. | $17.46 | 2024 | Topical Oxygen Chamber For Extremities |
| Sebela Pharmaceuticals INC. | $16.93 | 2021 | |
| Zyla Life Sciences, INC. | $16.06 | 2019 | |
| Pfizer INC. | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Stanton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.